415 Capital

General contacts
Investor type

VC

Founded

2018

AUM

$200 M

Location

Munich, Bavaria, Germany

Investment Ticket

$10-50 m

Investment Stage

Series B Series A Seed Pre-seed Late Stage (Series C+)

Region of investment

Europe North America Asia

ESG Focus

Impact investor
Investor profile last updated: 21 August, 2026

Profile

415 Capital is a specialist venture capital firm dedicated to investing in breakthrough and life-saving medical innovation. For over 30 years, our team has empowered exceptional entrepreneurs through the provision of capital, expertise, and market access.

We exclusively invest in large unmet patient needs in chronic diseases, with an emphasis on cardio & neurovascular disorders, the worldwide leading causes of death and the largest cost driver in the global healthcare systems. Our mission is to improve patient outcomes and quality of life at lower long-term healthcare costs.

Over the years, the 415 team has introduced over 25 breakthrough technologies to market and realized over 20 successful portfolio exits to-date, including Vesper Medical and Intact Vascular (both acquired by Philips), Claret Medical (acquired by Boston Scientific), ReCor Medical (acquired by Otsuka), CardiAQ Valve Technologies (acquired by Edwards), Atritech (acquired by Boston Scientific), CoreValve (acquired by Medtronic) and many more.

Industry

HealthTech MedTech AI Robotics Medical Devices Healthcare Services

415 Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region 		Size AUM Launch date
415 Capital Fund II
Venture Capital (VC)
Healthcare Services
Medical Devices
Robotics
HealthTech
Pre-seed
Seed
North America
Europe
$5-10 m
$164 M
October 2024

Contacts

Name
Title
Email
Social Networks
avatar
Ruben Osnabrugge Partner
Partner
r•••@•••
LinkedIn
avatar
Michael Braun Senior Venture Partner
Senior Venture Partner
m•••@•••
Upgrade to see contacts
avatar
Q9TpdxDztJ1abHW0 Q9TpdxDztJ1abHW0
Q9TpdxDztJ1abHW0
[email protected]
linkedin twitter
avatar
Q9TpdxDztJ1abHW0 Q9TpdxDztJ1abHW0
Q9TpdxDztJ1abHW0
[email protected]
linkedin twitter
avatar
Q9TpdxDztJ1abHW0 Q9TpdxDztJ1abHW0
Q9TpdxDztJ1abHW0
[email protected]
linkedin twitter
Investment-team contacts for 415 Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about 415 Capital

415 Capital is a venture capital firm. It backs companies at Series B, Series A, Seed, Pre-seed and Late Stage (Series C+), writing tickets of $10-50 m.
415 Capital is located in Munich, Bavaria, Germany.
415 Capital was founded in 2018.
415 Capital invests in companies and startups in HealthTech, MedTech, AI, Robotics, Medical Devices, Healthcare Services.
415 Capital invests in companies and startups in Europe, North America, Asia.
415 Capital invests in companies and startups at Series B, Series A, Seed, Pre-seed, Late Stage (Series C+).
415 Capital usually invests $10-50 m on average.
415 Capital has around $200m assets under management.
415 Capital last fund was created/launched in 2024-10-30
Yes, 415 Capital is impact investor.
415 Capital can be reached through its website 415capital.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for 415 Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query 415 Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.